🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rakovina Therapeutics Inc. (TSXV:RKV)
Canada flag Canada · Delayed Price · Currency is CAD
0.1650
+0.0100 (6.45%)
Nov 20, 2026, 1:12 PM EST

Rakovina Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
722761315
Market Cap Growth
148.49%-92.08%348.09%-52.61%-18.16%-
Enterprise Value
1142861112
Last Close Price
0.170.101.900.851.802.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.22----
PB Ratio
-15.146.211.632.091.80
P/TBV Ratio
--83.04-13.065.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.6818.580.330.36--
Net Debt / Equity Ratio
-1.5816.450.030.25-0.15-0.33
Net Debt / EBITDA Ratio
-0.59-0.30-0.03-0.460.391.36
Quick Ratio
0.100.120.722.958.5225.32
Current Ratio
0.150.271.174.099.9926.94
Return on Equity (ROE)
-1352.29%-391.14%-102.34%-54.02%-38.35%-129.24%
Return on Assets (ROA)
-138.86%-165.64%-71.52%-46.38%-37.77%-127.53%
Return on Capital Employed (ROCE)
-619.90%-642.10%-88.10%-49.70%-46.90%-29.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-192.94%-410.47%-15.26%-43.86%-22.21%-35.95%
Buyback Yield / Dilution
-81.77%-119.25%-18.18%-0.03%-30.22%-